About Jefferson Hospital
The number of people diagnosed with pancreatic cancer in 2017 was 53,670. The average life span after diagnosis is only six months and 71% of those diagnosed will not survive more than one year. The five year survival rate is less than 9%. Pancreatic Cancer will claim over 38,000 lives this year and is the least funded among major cancers in the U.S., with less than 2 percent of the National Cancer Institute’s research budget allocated to the disease.
Among the top programs in the country, Jefferson’s clinical and research team is poised to bring new breakthroughs in the field. Philanthropic support from events like ours brings discoveries to patients faster and makes truly transformational science possible.
Some of the proceeds from this fundraiser will be used to benefit pancreatic cancer research at Thomas Jefferson University and Hospitals where Amy (Cygan) Spier had received her care.
Jefferson is a registered 501(c)3 non-profit corporation (EIN 23-1352651).